IP Library Granted Patent US 8,697,846
Granted Patent B2
US 8,697,846 · App. 12/671,926 · Granted Apr 15, 2014

Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology

Inventor: James C. Zimring (Decatur, GA)
Assignee: Emory University
C07K16/00C12N5/0636C12N5/16C07K2319/00C07K16/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,846
App. No.
12/671,926
Granted
Apr 15, 2014
Kind
B2
Abstract

Disclosed are compositions and methods for related to monoclonal antibodies specific for single amino acid variation in an antigen.

Claims (13)

1. A method of making a monoclonal antibody comprising the steps of

a. administering to a subject CD4 T cells from a donor specific for a first antigen, wherein said CD4 T cells are of the same species as the subject and the donor and subject are MHC matched;

b. administering to a subject a cell comprising a chimeric antigen wherein the chimeric antigen comprises a first antigen linked to the terminal end of a second antigen, wherein the subject expresses a third antigen and wherein the third antigen differs from the second antigen by a single amino acid variation; and

c. generating a monoclonal antibody specific to the second antigen.

2. The method of claim 1 , wherein the subject is a mammal.

3. The method of claim 2 , wherein the mammal is a mouse.

4. The method of claim 1 , wherein the subject is transgenic for the third antigen.

5. The method of claim 1 , wherein the subject is tolerized to the third antigen.

6. The method of claim 1 , wherein the first antigen is a CD4 T cell epitope.

7. The method of claim 1 , wherein the CD4 T cells are isolated from a second subject comprising T-cell receptor (TCR) transgene specific for the first antigen.

8. The method of claim 1 , wherein the CD4 T cells are derived from a CD4 T cell line.

9. The method of claim 1 , wherein the second antigen is a blood antigen.

10. The method of claim 9 , wherein the blood antigen is selected from the listing of blood antigens consisting of Duffy A, Duffy B, Kell antigen K 1 , Kell antigen K 2 , S antigen, H substance, Yt(a), and Yt(b).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2011
From: ZIMRING, JAMES C.
To: EMORY UNIVERSITY
Reel/Frame 026161/0537 →
CONFIRMATORY LICENSE Recorded Apr 30, 2010
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024316/0856 →
Continuity (3)
Provisional Application 60964770 · Aug 15, 2007
Provisional Application 60969942 · Sep 4, 2007
Related Publication 20110191866A1 · Aug 4, 2011